Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
8.76
+0.06 (0.69%)
At close: Jan 16, 2026, 4:00 PM EST
8.70
-0.06 (-0.68%)
After-hours: Jan 16, 2026, 7:51 PM EST
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.28 billion as of January 16, 2026. Its market cap has decreased by -40.73% in one year.
Market Cap
2.28B
Enterprise Value
10.43B
1-Year Change
-40.73%
Ranking
Category
Stock Price
$8.76
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.28B, a decrease of -72.94%. That is a compound annual growth rate of -24.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.28B | 22.18% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |